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Neuropathic pain is chronic pain that develops after nerve injury and is less frequent 
in infants and children than in adults. Likewise, in animal models of neuropathic pain, 
allodynia and hyperalgesia are non-existent or attenuated in the infant, with a “switch” 
during development by which acute nerve injury transitions to chronic pain. Concomitant 
with the delay in neuropathic pain, there is a parallel delay in the ability of nerve injury to 
activate the immune system. Models of neuropathic pain in the infant have used various 
ligation methods and find that neuropathic pain does not occur under after postnatal 
days 21–28 (PN21–PN28), linked to activation of immune processes and developmental 
regulation of anti-inflammatory cytokines. We applied a model of neuropathic pain in 
the adult using a transient compression of the cervical nerve or nerve root in infant rats 
(injured at 10, 14, 21, or 28 days of age) to define transition periods during which injury 
results in no change in thermal and mechanical pain sensitivity or in short-term changes 
in pain. There was little to no hyperalgesia when the injury was imposed at PN10, but 
significant thermal hyperalgesia and mechanical allodynia 1 day after compression injury 
when performed at PN14, 21, or 28. Thermal withdrawal latencies returned to near 
baseline by 7 days postsurgery when the injuries were at PN14, and lasted up to 14 days 
when the injury was imposed at PN28. There was mechanical allodynia following injury 
at 1 day postinjury and at 14 days after injury at PN14. Measurements of mRNA from 
spinal cord at 1, 7, and 14  days postinjury at PN14, 21, and 28 showed that both 
the magnitude and duration of elevated immune markers and chemokines/cytokines 
were greater in the older animals, corresponding to the development of hyperalgesia. 
Thus, we confirm the late onset of neuropathic pain but found no evidence of emergent 
hyperalgesia if the injury was before PN21. This may be due to the use of a transient, and 
not sustained, compression ligation model.
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inTrODUcTiOn
As with all sensory systems, nociceptive circuits are plastic in infancy. Neonates respond to acute 
painful stimulation and show hyperalgesia after inflammatory injury at or before birth (1–6). 
Nonetheless nociceptive circuits and resultant pain processes develop and change well into postnatal 
life (1, 7–13). Neuropathic pain following peripheral nerve damage is one example of a process that 
Table 1 | summary of published peripheral nerve injury studies on pain during development.
Model age short-term pain long-term pain Mechanism reference
•	 Caudal trunk 
transection
PN0
PN10
Adult
•	 No effect for PN0 or PN10
•	 Immediate for adult
•	 Appeared at 4–6 weeks 
postinjury in PN0  
and PN10
(21)
•	 C-fiber stimulation PN10
Adult
•	 Allodynia 3–48 h in adult but not 
PN10
•	 Not tested •	 Spinal microglia activation only in 
adult
(23)
•	 L5, L6 ligation PN7
PN14
PN21
•	 Appeared when tested at PN21 
regardless of age of lesion
•	 Resolved at 6–8 weeks 
for PN7 and PN14 but not 
PN21
(19)
•	 Partial sciatic 
(Seltzer)
•	 Spinal nerve 
(Chung)
PN14
PN28
Adult
•	 PSL – no effect at PN14
•	 SNL – all ages allodynia 1 week 
postinjury (PN21, PN35)
•	 PN14 resolved 4–6 weeks
•	 PN28 resolved 7 weeks
•	 Adult resolved 8 weeks
(27)
•	 Spared nerve 
injury (SNI)
•	 Chr. constriction 
(PN10 only)
PN3
PN10
PN21
PN28
PN33
•	 SNI-PN3 no effect
•	 PN10 and 21 show non-specific 
transient allodynia. 7 days postop
•	 PN33 allodynic
•	 Only PN33 shows long-
term effect
•	 No reappearance
(20)
•	 SNI
•	 i.t. NMDA, LPS, 
or activated 
microglia
PN10
PN21
•	 Not tested for SNI
•	 LPS produces small but significant 
allodynia in PN10 and PN21
•	 Activated microglia had no effect
•	 Not tested •	 Spinal microglial markers less 
elevated at PN10 SNI
•	 NMDA and LPS elevated microglial 
markers at both ages
(22)
•	 SNI
•	 i.t. LPS
•	 i.t. ATP activated 
microglia
PN3
PN10
PN21
Adult
•	 Not reported •	 Not tested •	 Adult spinal microglia (3 days) and 
astrocyte (5 days) activation
•	 Infant microglia weak but early 
(1 day) robust astrocyte activation
(24)
•	 SNI PN10
Adult
•	 No immediate allodynia at PN10 •	 Not tested •	 Genes related to immune function 
activated only in adult DRG
•	 Macrophages cluster around 
A-fiber cell bodies only in adult
(25)
•	 SNI PN10
Adult
•	 No allodynia before PN21 •	 Appeared only at PN33 
after PN10 injury
•	 T-cells infiltrate the spinal cord in 
adults not infants
•	 Identify different genes expressed 
in adults vs. infants related to 
immune response
(17)
•	 SNI PN10
PN35
Adults
•	 No immediate allodynia at PN10 •	 Cold, mechanical, and 
weight bearing changes 
only after PN30. No thermal 
changes
•	 Upreg. of selective immune 
markers
•	 Anti-inflammatory IL-4 and IL-10 
cytokines are protective in infants
(48)
•	 SNI
•	 Minocycline 
or ketamine 
treatment
PN10 •	 No immediate allodynia at PN10 •	 Mechanical allodynia only 
after PN31. No thermal 
changes
•	 Allodynia accompanied by 
macrophage, microglial, and 
astrocyte activation
•	 NMDA dependent
(72)
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is immature in the infant. Phantom limb pain exists in children, 
but the incidence is 10-fold less than for adults. Complex regional 
pain syndrome is rare until adolescence. Brachial plexus avulsion 
often produces severe and debilitating pain in adults but not when 
it occurs obstetrically (14–16). Similarly in the rodent infant, 
regardless of the injury model or the age at which the injury 
occurs, changes in pain thresholds appear only when tested at 
21–33 days of age [(17–27); see Table 1]. In some studies, there 
was a delay between injury and decreased thresholds or an earlier 
resolution of the pain (19, 21, 27). Thus the increased propensity 
to develop neuropathic pain does not appear until early adoles-
cence in both the rat and human [reviewed in Ref. (14–16, 18)].
There are multiple mechanisms that have been proposed to 
be responsible for neuropathic pain [see Ref. (18, 28–36) for 
examples and reviews]. Injury activates both the innate (37–41) 
and adaptive immune (17, 41–44) systems and dampening the 
immune response reduces pain (45, 46). Thus, the immune sys-
tem is involved in the initiation and maintenance of neuropathic 
pain following peripheral or central nervous system damage (29, 
47). These immune processes may maintain neuropathic pain, 
which are then amenable to immune suppressant drugs. The 
mechanisms that induce and maintain neuropathic pain that 
are immature in the infant, or that may be protective, are largely 
unknown, although recently two inhibitory cytokines, IL-4 and 
FigUre 1 | (a) shows a schematic of the location of the microclips distal (nerve compression) and proximal (root compression) to the DRG. The nerve root 
compression was applied to the dorsal root as it exited the DRG. The nerve compression was of the mixed nerve just prior to its entering the DRG. (b) is a sample 
photomicrograph of myelin basic protein staining 14 days following root compression in a 28-day old animal (top) and a same age control (bottom). The arrow 
denotes the site of compression. We use these figures only to show the nature of the compression injury and not to imply any quantitative changes.
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IL-10 were overexpressed in the infant and protective, inhibiting 
neuropathic pain [(48); reviewed in Ref. (18)]. Concurrent with 
the lack of neuropathic pain is the limited ability of nerve injury 
to activate immune markers in the spinal cord or DRG (19–22, 
24, 25, 27). We do not fully know why the immune response to 
nerve damage is immature. Immune activation in neonates can be 
induced by other insults (e.g., ischemic brain injury; i.t. NMDA, 
Escherichia coli or LPS injection; and intraplantar carrageenan 
injection). It is not therefore, the inability of the immune system 
to respond but rather the inability of neural injury to activate the 
immune system.
The specific goal here is to understand the mechanisms 
that protect the infant from developing chronic neuropathic 
pain and how those mechanisms change as the infant matures. 
Studies of neuropathic pain in the infant have focused on 
peripheral nerve injury using a variety of models, almost all 
of which use some form of permanent/sustained nerve liga-
tion. We have adapted rat models of transient cervical nerve 
or root compression and applied them to infants (Figure 1A). 
This avoids potential interactions of ligation with nerve growth 
during early development and has not been tested in infants. In 
adult rodents, cervical root compression, a transient one-time 
event, induces long-term thermal and mechanical hyperalgesia 
(49, 50). In humans, the comparable injury is brachial plexus 
avulsion. To test the maturation of the behavioral and immune 
responses to this more transient injury, we induced the compres-
sion injury at 10–28 days of age and assessed pain responses 1, 
7, and 14 days later to bracket ages at which there are no effects 
on pain thresholds and when neuropathic pain first appears 
(19–27). In addition, we measured mRNA for immune related 
markers and cytokines at those time points. We found that the 
injury produced no neuropathic pain in infants, short-term allo-
dynia, and hyperalgesia that resolves quickly in weanlings and 
a longer lasting change in thermal pain thresholds in juveniles. 
Furthermore, the number, intensity, and duration of immune 
mRNA responses induced by injury increased with age and were 
greater following root injury than nerve injury. Our working 
hypotheses were that (1) nerve root compression activates the 
immune system, which is necessary but not sufficient to produce 
long-term pain; and (2) this activation follows the developmen-
tal course of neuropathic pain.
MaTerials anD MeThODs
subjects
Subjects were male and female Long–Evans rats from Harlan 
Labs (now Envigo) born in the CHOP colony maintained at 
21°C with a 12:12 light cycle. Food and water were available 
ad libitum. Cages were checked twice daily at 10 a.m. and 6 p.m. 
Table 2 | rough age equivalents between rats and humans.
rat human
PN10 Newborn
PN14 Early childhood
PN21 Early preadolescent child
PN28 Early adolescent, presexual maturity
PN is postnatal day.
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and the day of birth was defined as PN0. Pups were weaned 
at PN21, after behavior testing, and housed 2–3/cage for the 
remainder of the experiment. The Institutional Animal Care 
and Use Committees at CHOP approved all animal care and 
experimental procedures, which follow the guidelines from the 
National Institutes of Health.
experimental Design
Experimental groups were always within a single litter and 
included: central nerve root compression; peripheral nerve com-
pression, sham operated and naïve controls. Testing experimental 
groups within litters greatly reduces variability and increases 
power. No more than one condition was repeated in a single litter 
for any dependent measure. Surgery was performed on 10-, 14-, 
21-, or 28-day old animals. We tested for thermal hyperalgesia 
and tactile allodynia 1, 7, and 14 days postsurgery (PS1, PS7, and 
PS14) in the same animals, except for the PN10 animals who 
showed no or minimum pain at either 1 or 7 days and were not 
tested further. At each postoperative time point other animals 
were sacrificed for either immunohistochemistry or quantitative 
RT-PCR. We were not powered for rigorously testing sex differ-
ences, but preliminary analyses showed no differences for either 
thermal and mechanical behaviors. For PCR, the smaller N and 
uneven distribution of males and females made those compari-
sons impossible. Therefore, for all subsequent analyses male and 
female data were combined.
Our primary interest was root compression for comparison 
to the adult literature [Figure 1A; (50–52)]. We also tested nerve 
compression because with few exceptions the infant methods 
have damaged a nerve. Data for the sham root and sham nerve 
surgeries were very similar. Therefore, to reduce animal num-
bers, in some litters, a single root or nerve sham surgery was 
performed rather than both, and the data combined. A separate 
untreated group served as the non-surgical naïve controls, and 
withdrawal latencies for the left and right paws were averaged 
for those controls.
surgery
Compression was conducted in fully anesthetized rats aged 
10, 14, 21, or 28  days of age. These ages include the human 
equivalents of newborns through early adolescence (Table 2). 
All surgical procedures were performed under inhalation 
anesthesia (4% induction with isoflurane and 2% isoflurane 
maintenance with oxygen) using aseptic techniques. Breathing 
rate and hindpaw pinch response were monitored throughout 
surgery to ensure adequate depth of anesthesia. Rodents were 
placed in a prone position and any hair on the back of the neck 
was removed, and the area disinfected using Betadine, followed 
by alcohol and then covered with a sterile drape. Following a 
skin incision using a sterile scalpel, the right paraspinal muscles 
were separated from the spinous processes at the C4–T2 levels. 
The laminae, facet joint, and spinous process on the right side at 
C6–C7 were carefully exposed under a surgical microscope. The 
right transverse process was removed at the C7 level to expose 
the C7 nerve roots of interest. Central or peripheral nerve com-
pression was via surgical vessel microclips and was unilaterally 
applied to the C7 right mixed nerve or nerve root (Figure 1A). 
Compression was applied for 15  min and then removed. 
Microclips have been commonly used in other animal models 
of radiculopathy (49, 50, 53). Sham procedures were performed 
in separate groups of rats and involved all surgical procedures 
except that the nerve or root was not disturbed. After surgery, 
all wounds were washed with preservative-free sterile saline and 
closed in two layers (paravertebral muscle layer and skin) with 
monofilament suture and surgical glue. For the 10- and 14-day 
old pups, a commercially available nail biter/thumb sucking 
deterrent was placed near the surgical region to discourage the 
mother from disturbing the wound. Rats recovered in a cage 
warmed by a heating pad in room air and closely monitored by 
the surgeon for up to 1 h following surgery. Typically, most rats 
recovered from the effects of surgery within 10–20  min. This 
study of pain precluded the postlesion use of analgesics in all 
groups. The rats were monitored daily following surgery and did 
not exhibit any signs of distress or infection.
Tests for Thermal hyperalgesia
Thermal withdrawal latencies were assayed under non-restrained 
conditions for both forepaws. Each animal was placed singly 
within an inverted Plexiglas cage upon an elevated glass pane 
maintained at 30°C (e.g., Hargreaves apparatus). A radiant heat 
source (24 V halogen lamp focused through a convex lens to a 
2 × 4 mm area) beneath the glass was trained on the lateral plantar 
surface of the forepaw. The heat stimulus and an automatic timer 
were activated simultaneously. When the rat lifted its paw, the 
switch simultaneously turned off the stimulus and timer. Cut-off 
time was set at 20 s to avoid tissue injury.
Tests for Mechanical allodynia
The tactile sensitivity for both forepaws was measured as the 
latency to withdraw the paw to a mechanical probe. Each rat 
was previously acclimated to the environment and experimenter 
and gently restrained. In each session, a series of tactile stimuli 
were placed on the dorsal surface of each forepaw, just behind 
the interdigital web between the second and third toes. We used 
differing weighted probes that floated freely [3.3, 5.6, 7.5, 10.1 g; 
(54, 55)]. Latency to move the paw was measured. Because 
there were few interactions of the treatment with intensity, we 
averaged the response latency over the intensities. For all testing 
procedures, animals were free to remove themselves from the 
stimulus.
Dissection
Following testing, subjects were deeply anesthetized with a 
sodium pentobarbital and when fully unresponsive to pinches 
Table 3 | Function of immune markers from Figures 4 and 5.
IBA-1 Marker for macrophage/microglia activation
GFAP Marker for astrocytes
COX-2 Inducible enzyme for production of prostaglandins
TLR-4 Receptor for gram-negative bacteria (LPS); 
activates innate immune system
IL-1α Proinflammatory cytokine
IL-1β Proinflammatory cytokine
IL-4 Anti-inflammatory cytokine
IL-6 Proinflammatory cytokine
IL-10 Anti-inflammatory cytokine
CCL2 (MCP-1) Proinflammatory chemokine
CCL3 (MIP-1a) Proinflammatory chemokine
CCL5 (Rantes) Proinflammatory chemokine
TNFα Proinflammatory cytokine
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and air puffs, they were either transcardially perfused (4% 
paraformaldehyde) for IHC or decapitated for qPCR. Following 
perfusion, the spinal cord was dissected out and place overnight 
in paraformaldehyde. The cervical cord, just rostral to the com-
pression site, was blocked and placed in sucrose prior to cryostat 
sectioning. For qPCR, the spinal cord was rapidly removed and 
placed on ice. The cervical enlargement was isolated, and the 
dorsal cord above the central canal (separate for the ipsilateral 
and contralateral sides to the compression side) was removed, 
and frozen at −80°C until assayed.
Quantitative rT-Pcr
We assayed c-fos and a number of markers of immune related 
function, chemokines, and cytokines by quantitative RT-PCR 
(Taqman) in the dorsal spinal cord 1, 7, and 14 days postsurgery 
(except at PN10) in parallel with the behavioral studies. Each 
was chosen as a marker of immune related processes such as 
cyclooxygenase 2 (COX-2), toll-like receptor 4 (TLR-4), ionized 
calcium-binding adapter molecule 1 (IBA-1; for microglia) or 
Glial fibrillary acidic protein (GFAP; for astrocytes), or because 
they were inflammatory or anti-inflammatory cytokines and 
chemokines that have been implicated in chronic or neuropathic 
pain (see Table  3). Standard methods were used. Briefly, after 
homogenizing with guanidine-thiocyanate-containing lysis 
buffer, total RNA was isolated using RNeasy Mini Kit (Qiagen). 
Traces of DNA are then removed by DNase treatment on the 
column and the total RNA was eluted in RNase-free water. 
Five microgram DNase-treated total RNA from each sample 
was incubated with 50  pmol T7 (dT)24 primers (Affymetrix) 
at 70°C for 10 min. Using this RNA as a template, single-strand 
cDNA was synthesized by incubating with Reverse Transcriptase 
(SuperScript II RT, Invitrogen) as well as first Strand Buffer and 
10mM dNTP (Invitrogen) at 42°C for 1 h followed by 70°C for 
15  min to denature the enzymes. Newly synthesized ss-cDNA 
was diluted in pure H2O. Real-Time PCR was performed using 
a StepOne plus machine with TaqMan fast advanced master mix 
and Taqman primers (all Applied Biosystem), using the “Fast” 
protocol. The exceptions were IL-4 and IL-10 which were assayed 
by SYBR Green methods as previously described (56). To quanti-
tate the mRNA changes, we used the ΔΔCt method with GADPH 
as the reference primer. We have compared GADPH to S18 and 
β-actin and found identical results previously.
ihc
We stained 30 μm frozen floating sections for myelin basic pro-
tein 1 (Covalence) at a dilution of 1:1,000 using standard ABC 
protocols (57) as described previously (58). Controls include 
staining without the primary antibody. We did not quantitate the 
resulting micrographs.
statistical analysis
For the behaviors, withdrawal latencies were analyzed by two-way 
ANOVAs to determine overall significant differences. The two 
factors were lesion type (ipsilateral to compression, contralateral 
to compression, ipsilateral sham, and naïve animals) and days 
postsurgery. Because all surgeries were within litters and each 
animal was tested at each time point, both factors were considered 
matched values and analyzed by a repeated-measures ANOVA. 
Tukey’s multiple comparison tests were used to determine 
individual comparisons of the ipsilateral compression subjects to 
the naïve animals and to the ipsilateral sham controls. We did 
not compare the ipsilateral to the contralateral side because in 
some cases the contralateral side was altered as well, although not 
significantly. Those data are shown but not used in the statistical 
comparisons.
qPcr
The number of cycles for the naïve group (compared to GADPH) 
was subtracted from each experimental condition in the same 
litter and analyzed by a two-way ANOVA. Because all treatments 
were in a single litter, that analysis was repeated measures. Each 
time point was analyzed separately and Tukey tests for multiple 
comparisons were between the injured ipsilateral side and the 
ipsilateral sham control. The data are presented as fold change 
relative to the naïve animals.
resUlTs
histology
Neither root nor nerve compression induced gross qualitative 
changes in the dorsal horn structure (Figure  1B). We did not 
quantitate these results and thus cannot make conclusions about 
relative changes in myelin or cell density at different ages and 
times postinjury.
behavioral Tests
Figures 2 and 3 show the results of root or nerve compression 
on the thermal response latency. Comparisons were of the 
ipsilateral paw of the compressed root or compressed nerve 
to the ipsilateral paw sham and the naïve controls. In separate 
analyses, the contralateral side did not differ from either the 
FigUre 3 | The change in the forepaw response to the mechanical stimulus following root or nerve compression. Details are as in Figure 2. N = 8 for 
PN10 and PN28; N = 6 for PN14 and PN21.
FigUre 2 | The change in the forepaw response to the thermal stimulus following root or nerve compression. The age of surgery is above each panel 
and the X-axis denotes the time of testing postsurgery. The 95% confidence intervals for the naïve controls are denoted by the shaded area between the dashed 
lines. Significant differences from the naïve subjects are denoted by * and from the forepaw ipsilateral to the sham surgery by #. N = 8 except PN14, N = 6. 
*/#p < 0.05; **/##p < 0.01; ***/###p < 0.001; ****/####p < 0.0001.
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sham contralateral side or the naïve controls for the thermal 
test and only at one comparison for the mechanical test (PN14, 
PS1). F-values presented below are for the treatment ×  post-
surgical day interactions. Multiple comparison p-values are 
in Figures  2 and 3.
Thermal Tests
Neither root nor nerve compression at PN10 changed pain 
responses compared to the sham control [Root: F(6,42) = 0.731, 
p = 0.627; Nerve: F(6,42) = 0.998, p = 0.439] However, at PN14, 
PN21, and PN28, both nerve and root injuries produced a large 
Table 4 | summary of qPcr results.
Pn10 Pn14 Pn21 Pn28
Ps1 Ps7 Ps1 Ps7 Ps14 Ps1 Ps7 Ps14 Ps1      Ps7 Ps14
r r n r r n r n r r n r n r r n r n
c-fos * ** *
IBA-1 * ** ^ **** *
GFAP * *
COX-2 ^ **
TLR-4 ^^ ^^^ * ^ ** ** ^
IL-1α ^
IL-1β * * * ^ *** * **
IL-4
IL-6 ^ **** *** **** ^^
IL-10
CCL2 *** ^^^ **** ** ^^^^ * **** **** *** ^^^^ **** ^^
CCL3 **** **** ^ **** ^^^ **** *** **** ^^^ **** **** ^ ****
CCL5 * ** ***
TNFα ^
R is root compression; N is nerve compression.
*/^p < 0.05; **/^^p < 0.01; ***/^^^p < 0.001; ****/^^^^p < 0.0001.
Note that there are no data for nerve compression at PS1.
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reduction in the thermal response latency 1  day postsurgery 
[Root/PN14: F(9,45) = 1.489, p = 0.181; PN21: F(9,63) = 6.84, 
p  <  0.0001; PN28: F(9,63)  =  3.691, p  =  0.001; Nerve/PN14: 
F(9,45) =  3.237, p =  0.004; PN21: F(9,36) =  5.765, p <  0.001; 
PN28: F(9,45) = 1.982, p = 0.064]. At PN14, withdrawal latencies 
following root or nerve injury returned to control levels 7 and 
14  days postsurgery. At PN21, the root injuries reduced pain 
thresholds 1  day postoperatively, returning to control levels at 
PS7 and PS14. Nerve compression at PN21 showed a slightly 
different result with a return to control levels at PS7 but a reap-
pearing slight hyperalgesia at PS14. When either nerve or root 
compression was performed on PN28, the hyperalgesia lasted for 
14 days after surgery, the longest time tested.
Mechanical Tests
The mechanical allodynia results differed slightly from those 
of the thermal test. In separate analyses, the contralateral side 
never differed from either the sham contralateral side or the 
naïve controls, except at PN14, PS1. Again at PN10, there were 
no effects when compared to the ipsilateral sham control but 
there was a slight reduction (< 2 s) in latency compared to naïve 
controls for both root and nerve injury [Root: F(6,42) = 3.327, 
p =  0.010; Nerve: F(6,42) =  4.491, p =  0.001]. At PN14, 21, 
and 28, there was a short-term increase in sensitivity at PS1 
[Root/PN14: F(9,45) = 5.315, p = 0.002; PN21: F(9,36) = 9.915, 
p < 0.0001; PN28: F(9,63) = 5.425, p < 0.001, p = 0.001; Nerve/
PN14: F(9,45)  =  2.756, p  =  0.012; PN21: F(9,36)  =  6.056, 
p <  0.001; PN28: F(9,63) =  5.425, p <  0.001]. Following root 
injury, the withdrawal latencies returned to baseline levels by 
PS7 and PS14, regardless of the age of injury, except when 
performed at PN14. There was a reduction in the latency at PS14, 
largely because of increased latency in controls at those times 
that were actually higher than baseline latencies. For the nerve 
compression, at PN14, there was hyperalgesia at all postsurgical 
times. When surgery was performed at PN21 or 28, latencies 
returned to control levels by PS7 and PS14.
qPcr – root compression
There were several patterns that emerged from these data 
(Table  4; Figures  4 and 5). First, the number and levels of 
elevated markers were highest at 1  day postsurgery. However, 
at PN14 and to a lesser degree at PN21, the number and magni-
tude declined at later time points. The magnitude of changes at 
PN28 declined over time but the number of significant changes 
remained constant. Thus, overall activation of cytokines, 
chemokines, and other immune markers was more prolonged 
the older the animal at surgery (detailed below).
At PN10, only CCL2 was significantly elevated by root com-
pression compared to controls at PS1, and TNFα and CCL5 were 
significantly elevated at PS7.
By PN14, a number of proinflammatory cytokines were 
stimulated (IL-1β, IL-6, CCL2, and CCL5). This begins a pattern 
of consistent activation for CCL2 and CCL3, which were elevated 
at all postsurgical ages at PN14 and older. This activation declined 
such that by 7 days postsurgery, there were few differences and 
only CCL2 and CCL3 were at the twofold change level and sig-
nificantly different from controls. At PS14, the microglia marker, 
IBA-1 and IL-1β were significantly elevated in addition to CCL2 
and CCL3.
When injury occurred at PN21, 1 day postsurgery, there were 
significant changes in the IL-6, CCL2, and CCL3 at higher expres-
sion levels than at younger ages. The inflammatory chemokines 
CCL2 and CCL3 were expressed at 10–25-fold compared to con-
trols. Some proinflammatory cytokines/chemokines were also 
elevated on the contralateral side (IL-1β, CCl2, CCL3, and TNFα) 
but not to the extent of the injured side. Seven days postsurgery, 
IL-1β and CCL3 were significantly different from controls and 
many other immune markers were increased twofold, although 
FigUre 5 | change in mrna for immune related markers, cytokines, and chemokines at different times post-nerve compression at different ages in 
the dorsal horn of the spinal cord. N = 4 per group. Details as in Figure 4.
FigUre 4 | change in mrna for immune related markers, cytokines, and chemokines at different times post-root compression at different ages in 
the dorsal horn of the spinal cord. Note the change in the Y-axis scale for different postsurgical times. Asterisks denote statistical differences between the side 
ipsilateral to the compression and the ipsilateral side of the sham animals (see Figure 2). Also shown, but not tested statistically are the dorsal horn data 
contralateral to the injury. All fold change in the side ipsilateral to the injury are shown by hatched bars. The gray area bounds ±1.0 for which there are no values. 
The dashed lines are twofold levels. N = 4 per group.
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not statistically different from controls, where were also elevated. 
At 14 days postsurgery, there was still elevation of IBA-1, IL-1β, 
and CCL3.
At PN28, 1 day postsurgery, mRNA for COX-2, FOS, GFAP, 
TLR4, and the proinflammatory cytokines/chemokines, includ-
ing IL-1α, IL-1β, IL-6, CCL2, and CCL3 were all increased. 
At postsurgery day 7, many remained elevated and there was now 
increased expression of IBA-1 and GFAP. At postsurgery day 14, 
CCL2, CCL3, and IBA-1 remained significantly elevated. These 
data were consistent with those of others and confirm a late onset 
for immune activation following nerve injury.
There were some consistencies among those changes over time. 
IBA-1, the microglia marker, showed a delayed elevation at PS14 
in all three of the older animals. CCL2 and IL-6, in contrast, were 
elevated at PS1 at the three older ages. Likewise, IL-1β showed 
greater increases with age. CCL3 was elevated at all time points 
at PN14 and older. Only when surgery was at PN28, were c-fos, 
COX-2, GFAP, and TLR-4 were elevated.
qPcr – nerve compression
There were fewer changes at PS7 and PS14 following nerve injury 
than root injury and the levels were of lower magnitude, with the 
caveat that we did not assess changes at 1 day postsurgery. Only 
CCL3 was consistently elevated at PS14 at any age.
DiscUssiOn
Using a single brief compression injury to either the dorsal 
nerve root or to the nerve, we found an immediate (1  day) 
thermal hyperalgesia and mechanical allodynia when injury was 
at 14–28  days of age but minimally at PN10. This response, 
1  day after surgery, has often been reported for adult animals 
in multiple models [e.g., Ref. (59)]. However, consistent and 
prolonged thermal hyperalgesia was only seen when the surgery 
was at PN28. Mechanical allodynia was less prolonged lasting 
beyond 1  day postsurgery only at PN14. It is unclear why this 
occurred only at PN14, although the behavioral response to the 
mechanical stimulus was more variable in the older animals.
There were fewer and shorter-lasting changes in dorsal horn 
expression of proinflammatory cytokines/chemokines when root 
compression surgery was prior to PN28 with only CCL3, and 
to a lesser extent, CCL2, showing long lasting overexpression. 
However, at PN14, PN21, and PN28, IL-6 was upregulated on the 
first day postsurgery and returned to baseline 1 week postsurgery. 
Likewise, the microglial marker, IBA-1 was overexpressed at the 
later postsurgical times when surgery was conducted at those three 
ages. At PN21 and PN28, there was a particularly striking overex-
pression for CCL3, which showed a 40–75-fold change 1 day after 
surgery. At PN28, there were substantially greater numbers and 
levels of expression, including GFAP, TLR-4, COX-2, the interleu-
kin cytokines, and CCL2 and CCL3. Note that IBA-1 and TLR-4 
both increased when the animals were tested at 35 days of age 
regardless of whether the injury was at PN21 (tested at PS14) or 
PN28 (tested at PS7). The overexpression for most markers lasted 
at least 7 days, and CCL2 and CCL3 were continually expressed 
at high levels through the 14 days of postsurgical testing. These 
results are consistent with the demonstrated increased immune 
cell reaction and glial response to nerve injury with age [see Ref. 
(18) for a recent review].
The proinflammatory cytokines and chemokines are estab-
lished regulators of neuropathic pain and both mRNA and 
protein are elevated following nerve injury in adults. CCL2, 
CCL3, CCL5, IL-1β, and IL-6 are upregulated in damaged nerves, 
DRGs, and spinal cord dorsal horn (60–63) in variety of models 
and neuropathic pain is decreased by antagonists, neutralizing 
antibodies, microglia inhibitors, or in CCL2 deficient mice (62, 
64–66). However, in the present study, CCL3 expression was 
elevated at all ages at PS1 in the root compression and at PS7 in 
the nerve compression injury, which is not consistent with the 
appearance of thermal or mechanical hyperalgesia. It is possible 
that the early CCL2 expression is necessary but not sufficient to 
drive the behavioral changes.
CCL5 recruits leukocytes to a site of injury in the adult (67) 
and is upregulated by injury. Reduction of CCL5 by neutralizing 
antibodies reduces hyperalgesia. In the current experiments, 
CCL5 was only minimally upregulated root compression surgery 
at PS21 and PS28, and then only 14 or 7  days after surgery, 
respectively. CCL5 was not altered by nerve compression in any 
group. The lack of upregulation of CCL5 is consistent with at 
least one adult study using the partial sciatic nerve that reported 
upregulation of CCL1 and CCL3 but not CCL5 (68), although 
other studies using different models do report upregulation.
Nerve injury upregulates IL-6 and reduction of IL-6 reduces 
neuropathic pain (65, 69, 70). It has been proposed that TNFα 
upregulates IL-6 expression via a NF-κB pathway (71). Our results 
are not consistent with that since IL-6 was upregulated early in 
the root compression animals in the absence of change in TNFα.
Thermal hyperalgesia was similar for both nerve and root 
compressions with the exception of PN21 where latencies follow-
ing nerve compression returned to baseline 7 days postsurgery 
but were lower than controls at PS14. Thermal latencies were 
significantly reduced at PS7 but returned to control levels at PS14. 
Mechanical allodynia likewise was similar between the root and 
nerve compression treatments, but the effects differed from those 
of the thermal hyperalgesia. There was a slight allodynia at PN10 
for the nerve compression compared to naïve rats and for root 
compression, there was a difference at PS1 following root com-
pression, but again only compared to the naïve animals. When 
nerve compression was performed at PN14, there was a small but 
persistent allodynia that lasted until PS14, the last day tested.
There were several differences between the results with the 
compression model and those with various nerve ligation models 
(see Table 1). First, thermal hyperalgesia was more prolonged in 
the PN28-day old surgical animals compared to the mechanical 
allodynia. In contrast, in adult compression studies, mechanical 
allodynia is persistent (50). In developmental studies, the delayed 
appearance of neuropathic pain is specific for a mechanical 
stimulus, not thermal stimuli (17, 21, 72). There are at least two 
possible reasons for this. The first is the nature and duration of 
the injury. The compression as used here is brief whereas in the 
ligation models the injury is chronic. Thus ligation is a more 
continuous injury compared to single acute compression. This 
may be particularly important in infant and young animals where 
sensory neurons from the DRG are still growing during the first 
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week of life (73–75) perhaps changing the nature of the ligation 
as the axons grown. Second, the root injury was just proximal to 
the DRG and the nerve injury just distal to the DRG. As found 
here, the changes in pain sensitivity were similar between the two 
injuries but the nerve injury induced fewer changes in immune 
markers sensitivity particularly at PN28. We know of no root 
ligation models during early development, but dorsal rhizotomy 
(76) or dorsal root constrictions (77) produce neuropathic pain 
in the adult. Although there are no developmental dorsal root 
constriction models, dorsal rhizotomy in infants does not induce 
self-mutilation whereas it does in 40% of juveniles and 80% of 
adults (78). Third, the prior infant injury models induced nerve 
injury in the hindpaw/lumbar spinal cord whereas the injury 
described here was forepaw/cervical spinal cord. We know of no 
data suggesting differences however. Although we did not quan-
titate anatomical changes in the spinal cord here, future work 
should directly compare brief compression injury to comparable 
ligation models, including changes in dorsal horn structure and 
function to determine if those changes could account for differ-
ences among injury models.
We found no injury-induced changes in anti-inflammatory 
cytokines such as IL-4 and IL-10, despite the elegant data showing 
that these cytokines are developmentally regulated and actively 
suppress expression of proinflammatory cytokines/chemokines 
and neuropathic pain prior to 33 days of age in a spared nerve 
injury (SNI) model (48). We also found that these cytokines were 
overexpressed in the untreated infants relative to 42-day old rats. 
Both IL-4 and IL-10 were about three- to fourfold enriched at 
PN10–21 compared to adolescents. We did not measure protein 
levels of release of these cytokines. Thus, it is possible that expres-
sion of IL-4 and IL-10, although showing the normal reduction 
with age, did not reflect the changes following compression that 
were found in a ligation model (48), although others have reported 
greater expression of IL-4 in adults than infants using the SNI 
method (17). Alternatively, the single compression injury, unlike 
the SNI, may not stimulate the dominant anti-inflammatory 
response induced in that model.
Finally, our data are consistent with the existent literature that 
early injury does not induced neuropathic pain, possibly because 
of less immune activation, and extend those data to a nerve and 
nerve root compression injury. In the current studies, we did 
not find evidence of a delayed mechanical allodynia as reported 
previously (21, 48, 72). Further work will be needed to under-
stand these differences, identifying mechanisms that account for 
both the similar and different results and to extend them to other 
assays (e.g., cold allodynia) that also show onset of neuropathic 
pain after the third week of life in the rodent. Moreover, whether 
or not there are sex differences in the development of neuropathic 
pain at these ages is an important question given that there are 
sex differences in adults and that they are mediated by different 
components of the immune system [e.g., Ref. (79–82)].
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